A Test of Integrity for CDC Leadership
The Senate Health, Education, Labor, and Pensions (HELP) Committee convened Wednesday to vet two pivotal public health nominees: Dr. Erica Schwartz, tapped to lead the CDC, and Sean G. Kaufman, the choice for assistant secretary for preparedness and response at the Department of Health and Human Services.
Dr. Erica Schwartz, an occupational medicine physician with 24 years of service in the U.S. Navy and Coast Guard, faced pointed inquiries regarding scientific independence. Having previously served as deputy surgeon general, Schwartz identified the restoration of public trust in public health institutions as her primary objective.
Schwartz Faces Scrutiny Over Agency Autonomy
Committee members, including Chairman Sen. Bill Cassidy (R-La.), pressed Schwartz on whether she would adhere to directives that conflicted with her professional judgment. Schwartz stated she would “lead with integrity” and emphasized that she would “never betray the science.” When questioned by Ranking Member Bernie Sanders (I-Vt.) regarding vaccine safety, Schwartz affirmed her acceptance of scientific evidence confirming that vaccines do not cause autism.
Senators also raised concerns regarding the agency’s recent history. Members noted the short tenure of the previous CDC director, Susan Monarez, PhD, who was fired after just a month on the job after refusing requests made by HHS secretary Robert F. Kennedy Jr. In response, Schwartz stated she did not anticipate being asked to take actions that would violate the law or compromise public health.
Kaufman Questioned on mRNA and Vaccine Stance
Sean G. Kaufman, a senior advisor for Global Affairs at the CDC and former CEO of the consultancy Safer Behaviors, faced scrutiny over his views on mRNA vaccine research and past public statements.
Kaufman drew criticism from Sen. Cassidy after suggesting that research efforts should prioritize individuals who experienced adverse outcomes following COVID-19 mRNA vaccinations rather than focusing on the development of new mRNA applications. Cassidy noted that as the head of the agency responsible for developing countermeasures for emerging diseases, the nominee should support broad research initiatives.
Additionally, senators questioned Kaufman regarding a deleted LinkedIn post that appeared to link the hepatitis B vaccine birth dose to autism and allergy diagnoses. Kaufman stated that his comments were mischaracterized and that his intent was to highlight the need for further scientific understanding regarding the rise in autism and allergy cases. He reiterated his support for vaccination, noting that his own children are vaccinated.
Advocating for Localized Emergency Response
In response to questions from Sen. Lisa Murkowski (R-Alaska) regarding tribal health, Kaufman emphasized the importance of local leadership during crises. He criticized the “fly-in, fly-out” approach often utilized by emergency responders, stating that communities are best equipped to manage their own needs during disasters. He advocated for strategies that empower local stakeholders to lead response efforts, ensuring long-term stability rather than temporary interventions.
The Path to Confirmation
The Senate HELP Committee is now tasked with voting on whether to advance the nominations of Dr. Schwartz and Kaufman to the full Senate. Chairman Cassidy established a deadline of 5:00 p.m. ET on Thursday for committee members to submit further questions for the record. As Republicans hold a one-seat majority on the committee, both nominees require a simple majority to proceed to a full confirmation vote.
Worth a look